Open Access
Table IV
Subgroups of dm of interest to the oral and maxillfacial surgeon.
| DM with anti-NXP2 antibodies |
| These patients have a heightened association with the development of malignancy. Presence of severe dysphagia further worsens prognosis due to the risk of aspiration pneumonia, making oral healthcare impossible in the dental office More common in adult DM than JDM. Associated with a poor prognosis as 37.5% of patients with these antibodies develop advanced malignancy within 3 years of their appearance. |
| DM with anti-TIF-1γ antibodies |
| These patients are associated with an increased risk of developing malignancy as 50–70% of them develop cancer Ovoid palatal patch observed in 40% patients, making it a probable clinical indicator of the presence of a systemic malignancy. |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.